Also interesting
UCB invests in a bioproduction plant in Braine-l’Alleud
To support the launch of a new generation of products, UCB, the biopharmaceutical company specialized in neurology and immunology, is investing 300 million euros in the construction of an ultra-modern biological production plant at its site in Braine-l’Alleud...
Visit of the Belgian sovereigns Philippe and Mathilde to Afrigen Biologics
During their state visit to South Africa last March, Queen Mathilde and King Philippe visited the Afrigen biologics facilities in Cape Town to learn more about how two Belgian companies, Univercells and Etherna, are supporting the development of the first African-owned mRNA COVID-19 vaccine to further discuss cooperation and partnership between the two countries and focus, among other things, on business and development.
Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities at its European Center of Excellence for Cell Therapies in Gosselies
Catalent announced the completion and opening of a new commercial-scale cell therapy manufacturing facility at its European center of excellence for cell therapies, in Gosselies.